Featured Research

from universities, journals, and other organizations

Leukemia: Scientists make major breakthrough in understanding disease

Date:
August 14, 2014
Source:
Queen Mary, University of London
Summary:
Mutations in genes that lead to childhood leukemia of the acute lymphoblastic type -- the most common childhood cancer in the world -- have been discovered by researchers, advancing their understanding of the disease. Currently, one in six children in the general population does not respond well to standard therapy for leukemia, and/or suffers from relapses and toxic side-effects of therapy. These figures of poor response and toxicity are even bigger among children with Down's syndrome.

Scientists from Queen Mary University of London (QMUL) have discovered mutations in genes that lead to childhood leukemia of the acute lymphoblastic type -- the most common childhood cancer in the world.

The study was conducted amongst children with Down's syndrome -- who are 20-50 times more prone to childhood leukemias than other children -- and involved analysing the DNA sequence of patients at different stages of leukemia.

The researchers uncovered that two key genes (called RAS and JAK) can mutate to turn normal blood cells into cancer cells. However, these two genes never mutate together, as one seems to exclude the other. This discovery means we can begin to identify which of the two genes are mutated in patients, and therefore more effectively target their cancer in lower doses (reducing toxicity for the patient) with less side-effects.

This discovery is a significant step forward in understanding the biological mechanisms causing leukemia and will bring scientists closer to developing individually-tailored treatment.

Currently, one in six children in the general population does not respond well to standard therapy for leukemia, and/or suffers from relapses and toxic side-effects of therapy. These figures of poor response and toxicity are even bigger among children with Down's syndrome.

The study was a collaboration between researchers at QMUL's Blizard Institute, the Lee Kong Chian School of Medicine, Nanyang Technological University Singapore and Schools of Medicine of the Universities of Geneva and Padua, and is published in leading journal Nature Communications.

Dean Nizetic, Professor of Cellular and Molecular Biology at Queen Mary University of London, and Professor of Molecular Medicine at Lee Kong Chian School of Medicine, Singapore, comments: "We believe our findings are a breakthrough in understanding the underlying causes of leukemia and eventually we hope to design more tailored and effective treatment for this cancer, with less toxic drugs and less side-effects. This could benefit all children affected by the disease and potentially even cut the number of side effect-related deaths."

"Through our research we know people with Down's syndrome show signs of accelerated aging and have higher accumulation of DNA damage compared to age-matched general population. However, paradoxically, they seem to be protected from most common cancers in adult age. Also, some people with Down's syndrome appear protected from other aging-related diseases, such as dementia, atherosclerosis and diabetes. Therefore, studying cells from people with Down's syndrome could provide important clues in understanding the mechanisms of aging, Alzheimer's, cancer, atherosclerosis, diabetes, and a number of other common conditions. Further research is needed in this important area."


Story Source:

The above story is based on materials provided by Queen Mary, University of London. Note: Materials may be edited for content and length.


Journal Reference:

  1. Sergey I. Nikolaev, Marco Garieri, Federico Santoni, Emilie Falconnet, Pascale Ribaux, Michel Guipponi, Aoife Murray, Jόrgen Groet, Emanuela Giarin, Giuseppe Basso, Dean Nizetic, Stylianos E. Antonarakis. Frequent cases of RAS-mutated Down syndrome acute lymphoblastic leukaemia lack JAK2 mutations. Nature Communications, 2014; 5 DOI: 10.1038/ncomms5654

Cite This Page:

Queen Mary, University of London. "Leukemia: Scientists make major breakthrough in understanding disease." ScienceDaily. ScienceDaily, 14 August 2014. <www.sciencedaily.com/releases/2014/08/140814000952.htm>.
Queen Mary, University of London. (2014, August 14). Leukemia: Scientists make major breakthrough in understanding disease. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2014/08/140814000952.htm
Queen Mary, University of London. "Leukemia: Scientists make major breakthrough in understanding disease." ScienceDaily. www.sciencedaily.com/releases/2014/08/140814000952.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) — The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) — The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) — The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) — In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins